TLR4 and prostate cancer: Animal-SELEX was employed recently to identify bone targeting aptamer in a mouse model with prostate cancer bone metastasis [69], Toll-like receptor 4 (TLR4) blocking aptamers for use as acute stroke treatment [70], aptamers with the potential to be used as biomarkers for neurological disorders [71].